BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS
Marla C. Dubinsky 1
April Naegeli 2
Mingyang Shan 2
Sylvie Bradesi 2
Jochen Schmitz 2
Catherine Milch 2
Cem Kayhan 3
Simon Travis
1 Mount Sinai Hospital, Mount Sinai,New York City,United States
2 Eli Lilly and Company,Indianapolis,United States
3 Eli Lilly and Company,
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]